GC BIOPHARMA Trademark

Trademark Overview


On Monday, March 7, 2022, a trademark application was filed for GC BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the GC BIOPHARMA trademark a serial number of 97298515. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, October 10, 2025. This trademark is owned by Green Cross Holdings Corporation. The GC BIOPHARMA trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Medicines for humans used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors

Wholesale distributorships services featuring pharmaceutical products; Wholesale store services featuring biological preparations for medical purposes

Research and development of medicines; Research and development, scientific research in the field of pharmaceuticals, blood plasma preparations, recombinant proteins and antibodies; Scientific research in the fields of biomedicine; Research and development in the pharmaceutical and biotechnology fields
gc biopharma

General Information


Serial Number97298515
Word MarkGC BIOPHARMA
Filing DateMonday, March 7, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, October 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Description of MarkThe mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross are the stylized wording "GC Biopharma" in dark blue; the color white is not claimed as a feature of the mark and represents background and transparent areas only.
Goods and ServicesMedicines for humans used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of Immunodeficiency disease, Human Immunodeficiency Virus, rare disease; Biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors
Indication of Colors claimedThe color(s) green, yellow, orange, red, and dark blue is/are claimed as a feature of the mark.
Goods and ServicesWholesale distributorships services featuring pharmaceutical products; Wholesale store services featuring biological preparations for medical purposes
NOT AVAILABLE"BIOPHARMA"
Goods and ServicesResearch and development of medicines; Research and development, scientific research in the field of pharmaceuticals, blood plasma preparations, recombinant proteins and antibodies; Scientific research in the fields of biomedicine; Research and development in the pharmaceutical and biotechnology fields

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code005
First Use Anywhere DateTuesday, March 29, 2022
First Use In Commerce DateMonday, July 8, 2024

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code035
First Use Anywhere DateTuesday, March 29, 2022
First Use In Commerce DateMonday, July 8, 2024

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code042
First Use Anywhere DateTuesday, March 29, 2022
First Use In Commerce DateMonday, July 8, 2024

Trademark Owner History


Party NameGreen Cross Holdings Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressYongin-si, Gyeonggi-do 16924
KR

Party NameGreen Cross Holdings Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressYongin-si, Gyeonggi-do 16924
KR

Trademark Events


Event DateEvent Description
Thursday, March 10, 2022NEW APPLICATION ENTERED
Friday, March 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 12, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, October 28, 2022ASSIGNED TO EXAMINER
Friday, November 4, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, November 4, 2022EXAMINERS AMENDMENT E-MAILED
Friday, November 4, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 4, 2022EXAMINER'S AMENDMENT ENTERED
Friday, November 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 16, 2023SOU EXTENSION 1 FILED
Thursday, March 16, 2023SOU EXTENSION 1 GRANTED
Saturday, March 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 2 FILED
Wednesday, January 17, 2024SOU EXTENSION 2 GRANTED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2024SOU EXTENSION 3 GRANTED
Monday, July 22, 2024SOU EXTENSION 3 FILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 5, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, February 5, 2025SOU EXTENSION 4 FILED
Wednesday, February 5, 2025SOU EXTENSION 4 GRANTED
Wednesday, February 5, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 8, 2025USE AMENDMENT FILED
Thursday, May 8, 2025TEAS STATEMENT OF USE RECEIVED
Monday, July 22, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 10, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, October 10, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL